Innate Lymphoid Cells in Tumor Immunity
AbstractInnate lymphoid cells (ILCs) are a group of immune cells of the lymphoid lineage that do not possess antigen specificity. The group includes natural killer (NK) cells, lymphoid tissue inducer (LTi) cells and the recently identified ILC1s, ILC2s and ILC3s. Although the role of NK cells in the context of cancer has been well established, the involvement of other ILC subsets in cancer progression and resistance is just emerging. Here, we review the literature on the role of the different ILC subsets in tumor immunity and discuss its implications for cancer treatment and monitoring. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
van Beek, J.J.P.; Martens, A.W.J.; Bakdash, G.; de Vries, I.J.M. Innate Lymphoid Cells in Tumor Immunity. Biomedicines 2016, 4, 7.
van Beek JJP, Martens AWJ, Bakdash G, de Vries IJM. Innate Lymphoid Cells in Tumor Immunity. Biomedicines. 2016; 4(1):7.Chicago/Turabian Style
van Beek, Jasper J.P.; Martens, Anne W.J.; Bakdash, Ghaith; de Vries, I. J.M. 2016. "Innate Lymphoid Cells in Tumor Immunity." Biomedicines 4, no. 1: 7.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.